Research and News Involving:
Drug
This is where the drug category posts show up.
Adult, Chicago, Clinical Trials, Dr. Bjork, Dr. Kletzel, Dr. Lewine, Dr. Voigt-Zuwala, Drug, Edward Hines Jr. VA Hospital and CARES, Mid-Atlantic, Military/Veteran, Minority/Underrepresented, Neuro, Rush University Medical Center, University of New Mexico, Virginia Commonwealth University
Press Release: Two Clinical Trials Impacting US Veterans Now Underway Two Clinical Trials Impacting US Veterans Now Underway Cures Within Reach will select two more veterans’ focused clinical trials later in 2024 August 14, 2024 Cures Within Reach (CWR), a global...
Adult, Current Research, Dr. Bjork, Drug, Mid-Atlantic, Military/Veteran, Neuro, Virginia Commonwealth University
Daily Rotigotine Patch to Enhance Behavioral Therapy for Cocaine Use Disorder Recovery in Veterans Principal Investigator: Dr. James Bjork Disease: Cocaine Use Disorder Research Description: Veterans suffer from substance abuse at a higher rate than civilians. Cocaine...
Adult, Baylor College of Medicine, Brown University, Children's National Research Institute, Clinical Trials, Dr. Amorim, Dr. Holder, Dr. Shur, Drug, Health Disparities, Minority/Underrepresented, Neuro, Oncology, Pediatric, Rare Disease, University of California San Francisco
Press Release: Finalists Announced for CureAccelerator Live! for Diversity, Equity & Inclusion Competition Finalists Announced for CureAccelerator Live! for Diversity, Equity & Inclusion Competition Cures Within Reach’s Virtual Pitch Event on October 6...
Adult, Busitema University, Clinical Trials, Developing World, Dr. Adewole, Dr. Johnson, Dr. Malichewe, Dr. Musaba, Dr. Namazzi, Drug, Global Health Uganda, Infectious Disease, LMICs, Minority/Underrepresented, Muhimbili University Health and Allied Sciences, Neglected Tropical Diseases, Obafemi Awolowo University & Teaching Hospitals Complex, Oncology, Rare Disease, Université d'Abomey-Calavi, Women's Health
Press Release: Four clinical trials impacting high disease burden in LMICs will start soon Four clinical trials impacting high disease burden in LMICs will start soon Cures Within Reach also announces its latest success story and a multi-year grant from Open...
Adult, Brown University, Chicago, Children's National Research Institute, Clinical Trials, Developing World, Dr. Amorim, Dr. Holder, Dr. Ibraheem, Dr. Linnstaedt, Dr. Mondal, Dr. Musaba, Dr. Shur, Dr. Wesevich, Dr. Zimba, Drug, Health Disparities, International Centre for Diarrhoeal Disease Research Bangladesh, LMICs, Minority/Underrepresented, Neglected Tropical Diseases, Neuro, Oncology, Pediatric, Rare Disease, ReGRoW, University of California San Francisco, University of Chicago, University of Illinois at Chicago, University of North Carolina Chapel HIll, University of Zambia School of Medicine, Women's Health
Press Release: Eight clinical trials starting soon in health disparities and/or led by underserved researchers Eight clinical trials starting soon in health disparities and/or led by underserved researchers These Diversity, Equity & Inclusion trials funded by...
Adult, Chicago, Cincinnati Children's Hospital Medical Center, Clinical Trials, Developing World, Device, Drug, Emory University, Health Disparities, LMICs, Minority/Underrepresented, Neuro, Oncology, Pediatric, Rare Disease, Stanford University, University of California Los Angeles, University of Illinois at Chicago, Women's Health
Press Release: Nine clinical trials starting soon in health disparities and/or led by underserved researchers Nine clinical trials starting soon in health disparities and/or led by underserved researchers These Diversity, Equity & Inclusion trials, funded by Cures...
Clinical Trials, Drug, Oncology, Patient Impact Awards
Press Release: Cures Within Reach Names Eli Lilly and Company as Recipient of its 2021 Patient Impact Industry Award Cures Within Reach Names Eli Lilly and Company as Recipient of its 2021 Patient Impact Industry Award Lilly joins ReFRAME at Scripps Research/Calibr...
Adult, Clinical Trials, Device, Dr. Elfar, Dr. Oathes, Drug, Johns Hopkins Medicine, Mid-Atlantic, Military/Veteran, Neuro, Pennsylvania State University, University of Pennsylvania Medicine
Press Release: Cures Within Reach Launches Clinical Repurposing for Veterans Initiative to Impact Veterans with Unmet Medical Needs Cures Within Reach Launches Clinical Repurposing for Veterans Initiative to Impact Veterans with Unmet Medical Needs Initiative will...
Adult, Children's Hospital of Philadelphia, Clinical Trials, Dr. Fleischman, Dr. Park, Dr. Phillips, Dr. Seif, Drug, Mid-Atlantic, Oncology, Pediatric, Rare Disease, Stanford University, University of California Davis, University of California Irvine, University of Michigan
Press Release: Finalists Announced for CureAccelerator Live! for Rare Diseases 2020 Competition Finalists Announced for CureAccelerator Live! for Rare Diseases 2020 Competition Virtual Pitch Event on June 11 Features 5 Clinical Repurposing Projects April 21, 2020...
Adult, Clinical Trials, Dr. Nichols, Drug, Oncology, Pediatric, Rare Disease, St. Jude Children's Research Hospital
Press Release: St. Jude Researcher Wins CureAccelerator Live! for Rare Diseases St. Jude Researcher Wins CureAccelerator Live! for Rare Diseases Clinical Trial for Ultrarare Hemophagocytic Lymphohistiocytosis Receives Funding to Repurpose Existing Blood Cancer...
Adult, Clinical Trials, Dr. Nichols, Drug, Oncology, Pediatric, Rare Disease, St. Jude Children's Research Hospital
Press Release: Finalists Announced for CureAccelerator Live! for Rare Diseases Competition Finalists Announced for CureAccelerator Live! for Rare Diseases Competition Pitch Event on June 6 in Philadelphia Features 4 Clinical Repurposing Projects April 3, 2019 Cures...
Clinical Trials, Drug, Oncology, Patient Impact Awards
Press Release: The 2018 Global Health Repurposing Awards Honors Leaders in Cancer Repurposing The 2018 Global Health Repurposing Awards Honors Leaders in Cancer Repurposing Event Raises Funds to Support Cures Within Reach’s Medical Repurposing Research June 2,...
Adult, Children's Hospital of Philadelphia, Clinical Trials, Dr. Fleischman, Dr. Park, Dr. Phillips, Dr. Seif, Drug, Mid-Atlantic, Oncology, Pediatric, Rare Disease, Stanford University, University of California Davis, University of California Irvine, University of Michigan
Press Release: University of California, Irvine Researcher Wins CureAccelerator Live! for Rare Diseases University of California, Irvine Researcher Wins CureAccelerator Live! for Rare Diseases Clinical Trial in Myeloproliferative Neoplasms Receives Funding to...
Adult, Brigham Young University, Clinical Trials, Dr. Ghosh, Dr. Ito, Dr. Ohanian, Dr. Romancik, Dr. Watt, Drug, Emory University, Oncology, Pediatric, Rare Disease, The University of Texas MD Anderson Cancer Center, University of Michigan, University of Pittsburgh
Press Release: Five clinical trials impacting blood cancers approved for funding Five clinical trials impacting blood cancers approved for funding Cures Within Reach partnered with Goldman Philanthropic Partnerships, Leukemia Research Foundation and individual donors...
Adult, Baylor College of Medicine, Brown University, Children's National Research Institute, Clinical Trials, Dr. Amorim, Dr. Holder, Dr. Shur, Drug, Health Disparities, Minority/Underrepresented, Neuro, Oncology, Pediatric, Rare Disease, University of California San Francisco
Press Release: Brown University and UCSF Researchers Win CureAccelerator Live! for Diversity, Equity & Inclusion Brown University and UCSF Researchers Win CureAccelerator Live! for Diversity, Equity & Inclusion Clinical Repurposing Trials in Bladder Cancer...
Adult, Advocate Aurora Health, Chicago, Clinical Trials, Dr. Elfar, Drug, Edward Hines Jr. VA Hospital and CARES, Military/Veteran, Neuro, Pennsylvania State University, Rush University Medical Center, University of New Mexico
Press Release: Cures Within Reach announces upcoming clinical trials to address veterans’ issues Cures Within Reach announces upcoming clinical trials to address veterans’ issues These two new trials will join its Veterans Initiative research portfolio...
Adult, Cincinnati Children's Hospital Medical Center, Clinical Trials, Developing World, Device, Drug, Emory University, Health Disparities, Minority/Underrepresented, Neuro, Oncology, Rare Disease, SIDS Hospital and Research Centre, Stanford University, University College Hospital Ibadan, University of California Los Angeles, University of Illinois at Chicago
Press Release: Cures Within Reach seeks clinical trials in health disparities or led by underserved researchers Cures Within Reach seeks clinical trials in health disparities or led by underserved researchers Ten clinical trials starting soon in Diversity, Equity...
Adult, Clinical Trials, DEBRA Chile, Dr. Gordon, Dr. Rower, Dr. Teng, Drug, Minority/Underrepresented, Oncology, Pediatric, Rare Disease, Stanford University, The University of Texas MD Anderson Cancer Center, University of Utah
Press Release: Finalists Announced for Pediatric-Focused CureAccelerator Live! for Rare Diseases 2021 Competition Finalists Announced for Pediatric-Focused CureAccelerator Live! for Rare Diseases 2021 Competition Virtual Pitch Event on June 10 Features 4 Pediatric...
Clinical Trials, Drug, Patient Impact Awards
Press Release: Cures Within Reach Names Two Recipients of its 2021 Patient Impact Awards Cures Within Reach Names Two Recipients of its 2021 Patient Impact AwardsVirtual Pitch Event on June 10 Features 4 Pediatric Clinical Repurposing ProjectsReFRAME at Scripps...
Adult, Chicago, Clinical Trials, Dr. Liotta, Dr. Meltzer, Dr. Rado, Drug, Edward Hines Jr. VA Hospital and CARES, Health Disparities, Infectious Disease, Loyola University Medical Center, Military/Veteran, Neuro, Northwestern University, Oncology, Rare Disease, Shirley Ryan AbilityLab, University of Chicago, Women's Health
Press Release: Clinical Repurposing Trials for COVID-19 and Cerebral Palsy Underway in Chicago Clinical Repurposing Trials for COVID-19 and Cerebral Palsy Underway in Chicago Trials at the University of Chicago, Northwestern University and Shirley Ryan AbilityLab...
